Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antihistamine recommendations

This article was originally published in The Tan Sheet

Executive Summary

Allergies should be treated with newer, non-impairing, second-generation antihistamines rather than with older medications such as Pfizer's Benadryl, according to recommendations developed by a panel of 14 experts and published in the May Journal of Allergy and Clinical Immunology. Many antihistamines used to treat allergic rhinitis "may produce sedation, impairment and reduced quality of life," experts state, noting the condition is "more appropriately managed with the relatively non-impairing second-generation antihistamines" such as loratadine (Schering's Claritin). While "further epidemiologic studies on the effects of antihistamines should be performed," the expert group advises physicians that "second generation antihistamines are preferred for all patients"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel